Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey Allen

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancers|September 28, 2023
Inhibition of EphA3 Expression in Tumour Stromal Cells Suppresses Tumour Growth and ProgressionMary E Vail, Rae H Farnsworth, Linda Hii, et al.
Cancer Discovery|December 13, 2019
MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1Juming Yan, Stacey Allen, Elizabeth McDonald, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 26, 2024
Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with <sup>89</sup>Zr-labelled CI-8993Ingrid Julienne Georgette Burvenich, Christian Werner Wichmann, Alexander Franklin McDonald, et al.
Oncoimmunology|June 15, 2018
Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasisHeidi Harjunpää, Stephen J Blake, Elizabeth Ahern, et al.
Cancer Discovery|January 21, 2016
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer ImmunotherapyStephen J Blake, Kimberley Stannard, Jing Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2026
A Phase 1 and Biodistribution study of Ifabotuzumab, a humanized agonistic EphA3-targeted antibody, in patients with recurrent glioblastomaHui K Gan, Lawrence Cher, Po-Ling Inglis, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancers|September 28, 2023
Inhibition of EphA3 Expression in Tumour Stromal Cells Suppresses Tumour Growth and ProgressionMary E Vail, Rae H Farnsworth, Linda Hii, et al.
Cancer Discovery|December 13, 2019
MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1Juming Yan, Stacey Allen, Elizabeth McDonald, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 26, 2024
Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with <sup>89</sup>Zr-labelled CI-8993Ingrid Julienne Georgette Burvenich, Christian Werner Wichmann, Alexander Franklin McDonald, et al.
Oncoimmunology|June 15, 2018
Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasisHeidi Harjunpää, Stephen J Blake, Elizabeth Ahern, et al.
Cancer Discovery|January 21, 2016
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer ImmunotherapyStephen J Blake, Kimberley Stannard, Jing Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2026
A Phase 1 and Biodistribution study of Ifabotuzumab, a humanized agonistic EphA3-targeted antibody, in patients with recurrent glioblastomaHui K Gan, Lawrence Cher, Po-Ling Inglis, et al.
Pageof 2